Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-010033)

Filing Details

Accession Number:: 0001179110-14-010033
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-09 18:09:18
Reporting Period:: 2014-06-06

Filing Date:: 2014-06-09
Accepted Time:: 2014-06-09 17:09:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314981	T James Dalton	175 Toyota Plaza 7Th Floor Memphis TN 38103	Vp, Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-06-06	72,883	$1.30	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

An aggregate of 72,883 shares of common stock were sold in multiple trades on June 6, 2014 at prices ranging from $1.30 to $1.315. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.